WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013049617) CRYSTALLINE FORMS OF A 3-[2-METHANESULFONYL-1-(4-TRIFLUOROMETHYL-PHENOXY)ETHYL]PYRROLIDINE COMPOUND
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/049617    International Application No.:    PCT/US2012/057990
Publication Date: 04.04.2013 International Filing Date: 28.09.2012
IPC:
C07D 207/08 (2006.01), A61K 31/40 (2006.01), A61P 9/12 (2006.01), A61P 29/00 (2006.01), A61P 35/00 (2006.01)
Applicants: THERAVANCE, INC. [US/US]; 901 Gateway Boulevard South San Francisco, California 94080 (US) (For All Designated States Except US).
COLSON, Pierre-Jean [FR/US]; (US) (US only).
FASS, Timothy [US/US]; (US) (US only).
THALLADI, Venkat R. [IN/US]; (US) (US only)
Inventors: COLSON, Pierre-Jean; (US).
FASS, Timothy; (US).
THALLADI, Venkat R.; (US)
Agent: HAGENAH, Jeffrey A.; THERAVANCE, INC. 901 Gateway Boulevard South San Francisco, California 94080 (US)
Priority Data:
61/541,277 30.09.2011 US
Title (EN) CRYSTALLINE FORMS OF A 3-[2-METHANESULFONYL-1-(4-TRIFLUOROMETHYL-PHENOXY)ETHYL]PYRROLIDINE COMPOUND
(FR) FORMES CRISTALLINES D'UN COMPOSÉ 3-[2-MÉTHANESULFONYL-1-(4-TRIFLUOROMÉTHYL-PHÉNOXY)ÉTHYL]PYRROLIDINE
Abstract: front page image
(EN)The invention provides crystalline hydrochloride salts of (S)-3-[(S)-2-methanesulfonyl-1-(4-trifluoromethylphenoxy)ethyl]pyrrolidine. This invention also provides pharmaceutical compositions comprising the crystalline salts, processes and intermediates for preparing the crystalline salts, and methods of using the crystalline salts to treat diseases.
(FR)La présente invention concerne des sels cristallins de chlorhydrate de (S)-3-[(S)-2-méthanesulfonyl-1-(4-trifluorométhylphénoxy)éthyl] pyrrolidine. La présente invention concerne en outre des compositions pharmaceu­tiques comprenant les sels cristallins, des procédés et des intermédiaires pour préparer les sels cristallins, et des procédés d'utilisation des sels cristallins pour traiter des maladies.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)